全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Mapping Sentinel Lymph Nodes among Patients Afflicted with Skin Melanoma

DOI: 10.4236/oalib.1111282, PP. 1-13

Subject Areas: Oncology, Surgery & Surgical Specialties, Anatomy & Physiology

Keywords: Sentinel Lymph Node, Lymphoscintigraphy, Mapping

Full-Text   Cite this paper   Add to My Lib

Abstract

The network of lymphatic vessels in the skin has been studied for centuries. In 1984, Sappey published an atlas of lymphatic vessels. The discovery of lymphoscintigraphy around 1950 renewed interest in verifying the pathways of lymphatic vessels in patients with skin melanoma. Lymphoscintigraphy quickly became an indispensable technique for mapping sentinel lymph nodes. Detecting sentinel lymph nodes is essential for conducting adequate diagnostics, appropriately staging patients, and administering necessary therapy. A sentinel lymph node is any lymph node that drains lymph from the tumor site. It may not even be the closest to the tumor site because lymphatic vessels can bypass that group of lymph nodes and drain into other lymph nodes. Lymphoscintigraphy is used in mapping sentinel lymph nodes in patients with skin melanoma. It involves intradermal injections of a radiocolloid in close proximity to the melanoma site or in the vicinity where an excisional biopsy has been performed. The location of all lymphatics is marked with a marker or tattooed with a dot on the skin above the node. Radiocolloids particles used for sentinel identification are in the size range of 5 - 50 nanometers. These particles easily enter lymphatic capillaries, and their entry is facilitated by exercise or massage of that body part. The lymphatic drainage of the skin varies from patient to patient, sometimes even when the tumor is in the same location in two different individuals. Therefore, careful diagnostics will enable the location of all true sentinel lymph nodes.

Cite this paper

Vlač, M. , ić, Erić, M. , Jovanović, M. , Jelč, S. , ić, Beš, I. , enji and Smiljanić, I. (2024). Mapping Sentinel Lymph Nodes among Patients Afflicted with Skin Melanoma. Open Access Library Journal, 11, e1282. doi: http://dx.doi.org/10.4236/oalib.1111282.

References

[1]  Sappey, M.P.C. (1874) Anatomy, Physiology and Pathology of the Lymphatic Vessels in Man and Vertebrates. DeLahaye, A. and Lecrosnier, E., Trans.-Eds., Paris. (In French)
[2]  Sherman, A.I., Ter-Pogossian, M. and Tocus, E.C. (1953) Lymph Node Concentration of Radioactive Colloidal Gold Following Interstitial Injection. Cancer, 6, 1238-1240.
https://doi.org/10.1002/1097-0142(195311)6:6<1238::AID-CNCR2820060618>3.0.CO;2-6
[3]  Haagansen, C.D., Feind, C.R. and Herter, F.P. (1972) Lymphatics of the Trunk. In: Haagansen, C.D., Ed., The Lymphatics in Cancer, WB Saunders, Philadelphia, 437-458.
[4]  Sugarbaker, E.V. and McBride, C.M. (1976) Melanoma of the Trunk: The Results of Surgical Excision and Anatomic Guidelines for Predicting Nodal Metastasis. Surgery, 80, 22-30.
[5]  Bergqvist, L., Strand, S. and Hafstrom, L. (1984) Lymphoscintigraphy in Patients with Malignant Melanoma: A Quantitative and Qualitative Evaluation of Its Usefulness. European Journal of Nuclear Medicine, 9, 129-135.
https://doi.org/10.1007/BF00253515
[6]  Fee, H.J., Robinson, D.S. and Sample, W.F. (1978) The Determination of Lymph Shed by Colloidal Gold Scanning in Patients with Malignant Melanoma: A Preliminary Study. Surgery, 84, 626-632.
[7]  Meyer, C.M., Lecklitner, M.L. and Logic, J.R. (1979) Technetium-99m Sulfur-Colloid Cutaneous Lymphoscintigraphy in the Management of Truncal Melanoma. Radiology, 131, 205-209. https://doi.org/10.1148/131.1.205
[8]  Norman, J., Cruse, W. and Espinosa, C. (1991) Redefinition of Cutaneous Lymphatic Drainage with the Use of Lymphoscintigraphy for Malignant Melanoma. The American Journal of Surgery, 162, 432-437.
https://doi.org/10.1016/0002-9610(91)90255-C
[9]  Sullivan, D.C., Croker, B.P., Harris, C.C., Deery, P. and Seigler, H.F. (1981) Lymphoscintigraphy in Malignant Melanoma: 99mTc Antimony Sulfur Colloid. AJR, 137, 847-851. https://doi.org/10.2214/ajr.137.4.847
[10]  Morton, D.L., Wen, D.-R. and Wong, J.H. (1992) Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma. Archives of Surgery, 127, 392-399. https://doi.org/10.1001/archsurg.1992.01420040034005
[11]  Alex, J.C., Weaver, D.L. and Fairbank, J.T. (1993) Gamma-Probe-Guided Lymph Node Localization in Malignant Melanoma. Surgical Oncology, 2, 303-308.
https://doi.org/10.1016/S0960-7404(06)80006-X
[12]  Krag, D.N., Meijer, S.J., Weaver, D.L., et al. (1995) Minimal-Access Surgery for Staging of Malignant Melanoma. Archives of Surgery, 130, 654-658.
https://doi.org/10.1001/archsurg.1995.01430060092018
[13]  Dummer, R., Hauschild, A., Lindenblatt, N., Pentheroudakis, G., Keilholz, U. and ESMO Guidelines Committee (2015) Cutaneous Melanoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 26, V126-V132. https://doi.org/10.1093/annonc/mdv297
[14]  Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Bastholt, L., et al. (2016) Diagnosis and Treatment of Melanoma. European Consensus-Based Interdisciplinary Guideline—Update 2016. European Journal of Cancer, 63, 201-217.
https://doi.org/10.1016/j.ejca.2016.05.005
[15]  Pflugfelder, A., Kochs, C., Blum, A., Capellaro, M., Czeschik, C., Dettenborn, T., et al. (2013) S3-Guideline, “Diagnosis, Therapy and Follow-Up of Melanoma” Short Version. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 11, 563-602.
https://doi.org/10.1111/ddg.12044
[16]  NCCN Clinical Practice Guidelines in Oncology V2.2018.
https://www.nccn.org/guidelines/category_1
[17]  Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand 2018.
[18]  Wong, S.L., Faries, M.B., Kennedy, E.B., Agarwala, S.S., Akhurst, T.J., Ariyan, C., et al. (2018) Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. Annals of Surgical Oncology, 25, 356-377. https://doi.org/10.1245/s10434-017-6267-7
[19]  Bluemel, C., Herrmann, K., Giammarile, F., Nieweg, O.E., Dubreuil, J., Testori, A., et al. (2015) EANM Practice Guidelines for Lymphoscintigraphy and Sentinel Lymph Node Biopsy in Melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 42, 1750-1766. https://doi.org/10.1007/s00259-015-3135-1
[20]  Uren, R.F., Thompson, J.F. and Howman-Giles, R.B. (1999) Lymphatic Drainage of the Skin and Breast: Locating the Sentinel Nodes. Harwood Academic Publishers, Amsterdam.
[21]  Uren, F.R., Howman-Giles, R. and Thompson, F.J. (2003) Patterns of Lymphatic Drainage from the Skin in Patients with Melanoma. Journal of Nuclear Medicine, 44, 570-582.
[22]  Mar, M.V., Miller, S.A., Kim, E.E. and Macapinlac, H.A. (2007) Evaluation and Localization of Lymphatic Drainage and Sentinel Lymph Nodes in Patients with Head and Neck Melanomas by Hybrid SPECT/CT Lymphoscintigraphic Imaging. Journal of Nuclear Medicine Technology, 35, 10-16.
[23]  Leak, L.V. (1980) Lymphatic Vessels. In: Johannessen, J.V., Ed., Cardiovascular System, Lymphoreticular and Hematopoietic System, McGraw-Hill, New York, 159-183.
[24]  Ryan, T.J. (1978) The Lymphatics of the Skin. In: Jarrett, A., Ed., The Physiology and Pathophysiology of the Skin, Academic Press, London, 1755-1780.
[25]  Uren, R.F., Howman-Giles, R.B. and Thompson, J.F. (1997) Variation in Cutaneous Lymphatic Flow Rates. Annals of Surgical Oncology, 4, 279-280.
https://doi.org/10.1007/BF02306624
[26]  Sjoberg, T. and Steen, S. (1991) Contractile Properties of Lymphatics from the Human Lower Leg. Lymphology, 24, 16-21.
[27]  Mariani, G., Gipponi, M. and Moresco, L. (2002) Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma. Journal of Nuclear Medicine, 43, 811-827.
[28]  Eberbach, M.A. and Wahl, R.L. (1989) Lymphatic Anatomy: Functional Nodal Basins. Annals of Plastic Surgery, 22, 25-31.
https://doi.org/10.1097/00000637-198901000-00005
[29]  Bergqvist, L., Strand, S.-E. and Persson, B.R.R. (1983) Particle Sizing and Biokinetics of Interstitial Lymphoscintigraphic Agents. Seminars in Nuclear Medicine, 8, 9-19. https://doi.org/10.1016/S0001-2998(83)80031-2
[30]  Strand, S.E. and Persson, B.R.R. (1979) Quantitative Lymphoscintigraphy I: Basic Concepts for Optimal Uptake of Radiocolloids in the Parasternal Lymph Nodes of Rabbits. Journal of Nuclear Medicine, 20, 1038-1046.
[31]  Giammarile, F., Alazraki, N., Aarsvold, J.N., et al. (2013) The EANM and SNMMI Practice Guideline for Lymphoscintigraphy and Sentinel Node Localization in Breast Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 40, 1932-1947. https://doi.org/10.1007/s00259-013-2544-2
[32]  O’Brien, C.J., Uren, R.F. and Thompson, J.F. (1995) Prediction of Potential Metastatic Sites in Cutaneous Head and Neck Melanoma Using Lymphoscintigraphy. The American Journal of Surgery, 170, 461-466.
https://doi.org/10.1016/S0002-9610(99)80330-4
[33]  Uren, R.F., Howman-Giles, R.B. and Thompson, J.F. (1995) Lymphatic Drainage from Peri-Umbilical Skin to Internal Mammary Nodes. Clinical Nuclear Medicine, 20, 254-255. https://doi.org/10.1097/00003072-199503000-00013
[34]  Morton, D.L., Thompson, J.F., Cochran, A.J., et al. (2014) Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma. The New England Journal of Medicine, 370, 599-609. https://doi.org/10.1056/NEJMoa1310460
[35]  Pasquali, S. and Spillane, A. (2014) Contemporary Controversies and Perspectives in the Staging and Treatment of Patients with Lymph Node Metastasis from Melanoma, Especially with Regards Positive Sentinel Lymph Node Biopsy. Cancer Treatment Reviews, 40, 893-899. https://doi.org/10.1016/j.ctrv.2014.06.008
[36]  Pasquali, S., Mocellin, S., Campana, L.G., et al. (2010) Early (Sentinel Lymph Node Biopsyguided) versus Delayed Lymphadenectomy in Melanoma Patients with Lymph Node Metastases: Personal Experience and Literature Meta-Analysis. Cancer, 116, 1201-1209. https://doi.org/10.1002/cncr.24852
[37]  Morton, D.L. (2012) Overview and Update of the Phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in Melanoma. Clinical & Experimental Metastasis, 29, 699-706. https://doi.org/10.1007/s10585-012-9503-3
[38]  McNeil, C. (2013) Does Every Melanoma Patient with a Positive Sentinel Node Need More Lymph Nodes Removed? The ASCO Post Website.
http://www.ascopost.com/issues/may-1,-2013/higher-her2-expression-linked-to-best-results-with-t-dm1-inpatients-with.aspx
[39]  Kuhl, D.E. and Edwards, R.Q. (1970) The Mark 3 Scanner: A Compact Device for Multiple-View and Section Scanning of the Brain. Radiology, 96, 563-570.
https://doi.org/10.1148/96.3.563
[40]  Ter-Pogossian, M.M., Phelps, M.E., Hoffman, E.J. and Mullani, N.A. (1975) A Positron-Emission Transaxial Tomograph for Nuclear Imaging (PETT). Radiology, 114, 89-98. https://doi.org/10.1148/114.1.89
[41]  Beyer, T., Townsend, D.W., Brun, T., Kinahan, P.E., Charron, M., Roddy, R., et al. (2000) A Combined PET/CT Scanner for Clinical Oncology. Journal of Nuclear Medicine, 41, 1369-1379.
[42]  Even-Sapir, E., Lerman, H., Lievshitz, G., Khafif, A., Fliss, D.M., Schwartz, A., et al. (2003) Lymphoscintigraphy for Sentinel Node Mapping Using a Hybrid SPECT/CT System. Journal of Nuclear Medicine, 44, 1413-1420.
[43]  Kretschmer, L., Altenvoerde, G., Meller, J., Zutt, M., Funke, M., Neumann, C., et al. (2003) Dynamic Lymphoscintigraphy and Image Fusion of SPECT and Pelvic CT-Scans Allow Mapping of Aberrant Pelvic Sentinel Lymph Nodes in Malignant Melanoma. European Journal of Cancer, 39, 175-183.
https://doi.org/10.1016/S0959-8049(02)00534-8
[44]  Van Der Ploeg, I.M.C., Valdes Olmos, R.A., Nieweg, O.E., Rutgers, E.J.T., Kroon, B.B.R. and Hoefnagel, C.A. (2007) The Additional Value of SPECT/CT in Lymphatic Mapping in Breast Cancer and Melanoma. Journal of Nuclear Medicine, 48, 1756-1760. https://doi.org/10.2967/jnumed.107.043372
[45]  Uren, R.F. (2009) SPECT/CT Lymphoscintigraphy to Locate the Sentinel Lymph Node in Patients with Melanoma. Annals of Surgical Oncology, 16, 1459-1460.
https://doi.org/10.1245/s10434-009-0463-z

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413